Description
Komboglyze is a prescription medication designed to improve blood sugar control in adults with type 2 diabetes mellitus. It is used in conjunction with diet and exercise to enhance glycemic control. The medication consists of two active ingredients, saxagliptin and metformin hydrochloride.
Saxagliptin belongs to a class of drugs known as dipeptidyl peptidase-4 (DPP-4) inhibitors, which work by increasing the levels of incretin hormones, improving the release of insulin when needed, and decreasing the amount of sugar produced by the liver. Metformin hydrochloride is a biguanide which reduces glucose production in the liver, decreases glucose absorption in the intestines, and enhances insulin sensitivity by increasing peripheral glucose uptake and utilization.
Reviews
There are no reviews yet.